1 unchanged sentence
Our common shares trade on the Nasdaq Global Select Market under the symbol “ABUS” following our name change to Arbutus Biopharma Corporation on July 31, 2015.
−Removed: As of March 3, 2022, there were 103 registered holders of common shares and 148,641,736 common shares issued and outstanding.
+Added: As of February 28, 2023, there were 103 registered holders of common shares and 162,570,989 common shares issued and outstanding.
Securities Authorized for Issuance under Equity Compensation Plans
1 unchanged sentence
Recent Sales of Unregistered Securities
−Removed: We did not issue any unregistered equity securities during the year ended December 31, 2021.
+Added: Other than as previously disclosed on our Current Reports on Form 8-K or Quarterly Reports on Form 10-Q, we did not issue any unregistered equity securities during the twelve months ended December 31, 2022.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.